Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FabricNano is a biotechnology company developing a platform for cell-free biomanufacturing using DNA nanotechnology. The company's core technology involves using DNA as a programmable scaffold to organize enzymes, creating highly efficient biocatalysts that outperform traditional fermentation methods. By eliminating the need for living cells, FabricNano's approach reduces the complexity and cost of producing bio-based chemicals and materials. The platform is designed to be modular and scalable, targeting applications across the pharmaceutical, chemical, and materials industries. Their mission is to accelerate the world's transition to sustainable manufacturing through advanced synthetic biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FabricNano.